article thumbnail

FDA approves Analog and Dipharma’s ANDA for nitisinone capsules

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted clearance to Analog Pharma and Dipharma’s abbreviated new drug application (ANDA) for 20mg nitisinone capsules. Some of the most common side effects of nitisinone include low platelet count, elevated tyrosine levels, eye pain, white or cloudy cornea from scarring, and pink eye.

article thumbnail

Why There's No Such Thing as a 'Safe' Drug?

Contrarian Sales Techniques

This includes potential side effects or adverse reactions to medications. The results of these studies are carefully analyzed and scrutinized by regulatory bodies, such as the FDA in the United States. This is before a drug can be approved for public use.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

Second, the production and delivery of CAR T cells necessitates close collaboration between the pharma industry and academic (usually transplant) departments. Approved cellular and gene therapy products [Internet]. FDA; 2022 [cited 2023 Mar]. 2021;3(S1):6–10. Center for Biologics Evaluation and Research.

article thumbnail

Unveiling the Roadmap: Navigating Medical Sales Rep Requirements

Rep-Lite

Even the knowledge of healthcare economics helps communicate the value proposition of their products in the context of cost-effectiveness and improved patient outcomes. Pharmaceutical Knowledge Thorough pharmaceutical product knowledge in pharmaceutical sales includes therapeutic indications, dosing, and side effects.